116
Views
7
CrossRef citations to date
0
Altmetric
Review

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections

, , , , &
Pages 243-265 | Published online: 03 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matteo Bassetti & Elda Righi. (2016) Safety profiles of old and new antimicrobials for the treatment of MRSA infections. Expert Opinion on Drug Safety 15:4, pages 467-481.
Read now
O. Smibert, G. I. Snell, H. Bills, G. P. Westall & C. O. Morrissey. (2016) Mycobacterium abscessus Complex – a Particular Challenge in the Setting of Lung Transplantation. Expert Review of Anti-infective Therapy 14:3, pages 325-333.
Read now

Articles from other publishers (5)

Chuanhua Zhou, Xi Chen, Tong Lv, Xu Han, Jinhui Feng, Weidong Liu, Qiaqing Wu & Dunming Zhu. (2023) Flipping the Substrate Creates a Highly Selective Halohydrin Dehalogenase for the Synthesis of Chiral 4-Aryl-2-oxazolidinones from Readily Available Epoxides. ACS Catalysis 13:7, pages 4768-4777.
Crossref
Fumiya Ebihara, Yukihiro Hamada, Hideo Kato, Takumi Maruyama & Toshimi Kimura. (2022) Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan. International Journal of Environmental Research and Public Health 19:5, pages 2516.
Crossref
Alicia Rodríguez-Gascón, Amaia Aguirre-Quiñonero, María Angeles Solinís Aspiazu & Andrés Canut-Blasco. (2021) Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria. Antibiotics 10:7, pages 755.
Crossref
Kavindra V. Singh, Cesar A. Arias & Barbara E. Murray. (2019) Efficacy of Tedizolid against Enterococci and Staphylococci, Including cfr + Strains, in a Mouse Peritonitis Model . Antimicrobial Agents and Chemotherapy 63:4.
Crossref
S. Flanagan, S. L. Minassian, D. Morris, R. Ponnuraj, T. C. Marbury, H. W. Alcorn, E. Fang & P. Prokocimer. (2014) Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment. Antimicrobial Agents and Chemotherapy 58:11, pages 6471-6476.
Crossref